Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

496 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Completed

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

NCT03366337

Conditions
Abnormalities, Multiple, Autoimmune Diseases, Autosomal Dominant Polycystic Kidney, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenician Centers for Research & Innovation (PCRI) Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Denver Nephrology Denver, Colorado, United States
View all 30 locations
View Trial Details
Completed

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

NCT01613118

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +9 more
Locations
  • Balboa Nephrology Medical Group San Diego, California, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • Colorado Kidney Care Denver, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 33 locations
View Trial Details
Completed

Rituximab and RASi in Patients with IgAN

NCT04525729

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

NCT03301467

Conditions
C3 Glomerulopathy (C3G), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations
  • Clinical Site Palo Alto, California, United States
  • Clinical Site Chicago, Illinois, United States
  • Clinical Site Iowa City, Iowa, United States
  • Clinical Site Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

A Study of CCX140-B in Subjects With FSGS

NCT03536754

Conditions
FSGS, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • AKDHC Phoenix, Arizona, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • Northwest Louisiana Nephrology Shreveport, Louisiana, United States
  • MGH Boston, Massachusetts, United States
View all 37 locations
View Trial Details
Completed

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

NCT02384317

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Palo Alto, California, United States
  • San Francisco, California, United States
  • Reno, Nevada, United States
  • Chapel Hill, North Carolina, United States
View Trial Details

Related conditions